Doctors 2.0 TM & You and Creation Healthcare have announced a research partnership that will reveal for the first time how healthcare professionals (HCPs) discuss cardiovascular disease and treatments using public social media channels. The research is being conducted using Creation Pinpoint, the world's first social media monitoring tool dedicated to studying public conversations among HCPs, and will be presented at Doctors 2.0 & You in Paris, June 6 - 7, 2013.

Researchers at the University of Warwick and The Royal Marsden NHS Foundation Trust have completed a study that may lead to clinicians being able to more accurately predict which patients will suffer from the side effects of radiotherapy. Gastrointestinal side effects are commonplace in radiotherapy patients and occasionally severe, yet there is no existing means of predicting which patients will suffer from them.

The growing ease of DNA sequencing has led to enormous advancements in the scientific field. Through extensive networked databases, researchers can access genetic information to gain valuable knowledge about causative and preventative factors for disease, and identify new targets for future treatments.

The European Commission today announced the winners of a multi-billion euro competition of Future and Emerging Technologies (FET). The winning Graphene and Human Brain initiatives are set to receive one billion euros each, to deliver 10 years of world-beating science at the crossroads of science and technology. Each initiative involves researchers from at least 15 EU Member States and nearly 200 research institutes.

Scientists at the Academy of Finland's Centre of Excellence in Computational Inference Research have developed novel computational methods that have yielded essential knowledge of how hospital-acquired bacteria spread and develop. These new methods, based on randomised algorithms, make it possible to analyse extensive genomic data significantly faster and more efficiently than previously.

A software tool called PredictAD developed by VTT Technical Research Centre of Finland promises to enable earlier diagnosis of the disease on the basis of patient measurements and large databases. Alzheimer's disease currently takes on average 20 months to diagnose in Europe. VTT has shown that the new method could allow as many as half of patients to get a diagnosis approximately a year earlier.

Writing in the journal Science, Professor Derby of The School of Materials, looks at how the concept of using printer technology to build structures in which to grow cells, is helping to regenerate tissue. Both inkjet and laser printer technology can be used to build the 3D scaffolds that cells can be grown in and also place the cells in these structures simultaneously.